Capital Markets Advisors

Turning Change Into Opportunity

  • What has become clear is that almost nothing is clear about how fees and rebates impact both execution decision-making and execution quality, so the SEC’s social experiment is a worthwhile effort. We just need to make sure that it yields the most reliable results possible. In that regard, we should understand the many risks and… Read More »

  • Participants in the world’s financial markets are facing a period of unprecedented challenges, affecting not only the markets for financial instruments but even more the markets for financial services. These challenges, while often appearing unconnected, are actually evidence of a complicated process of evolution in the markets. Capital Markets Advisors Partner George Bollenbacher’s guide to… Read More »

  • Among the regulatory requirements that have crept up to bite us,  none appear to be more troublesome than the reporting of complex trades. With global regulators attacking the issue independently, disparate requirements are complicated and often unclear. CMAs George Bollenbacher breaks down just how complicated reporting obligations can be.   Check out the full article on TabbForum here:

  • The recent global hack attack using algorithms apparently stolen from the NSA should focus our attention on the safety of the electronic information floating around the world’s capital markets, particularly in light of MiFID II’s personal data reporting requirements. But the EU’s new Global Data Protection Requirement should provide some comfort, shouldn’t it? CMA’s George Bollenbacher… Read More »

  • Having trouble following and understanding all of the new market regulations coming out of Europe? Looking for a guide to MiFID? MiFID II? MAR? MAD? Download and read through CMA’s new EU Regulations Series in which George Bollenbacher explores various EU market regulations and their effects.

  • What happens if and when one of the large CCPs runs into a major default by one or more of its members? George Bollenbacher, CMA’s Head of Regulatory Reform, takes a deep dive into the risks and regulatory requirements.

CMA is a results-oriented professional boutique-consulting firm with a specialized focus in capital markets. Our resources are highly experienced, averaging over 10 years of experience in financial services working at the major financial institutions. CMA resources bring a broad set of tools and market knowledge to firms and situations that need to be addressed with confidence in execution as well as expeditious delivery.



Values and Mission


Clients First – At CMA, Clients First means delivering results, keeping our clients’ best interests to heart, and delivering on our promises. We strive to develop long-term partnerships with our clients and as such provide a high-impact, collaborative approach. CMA brings the best of our team to every engagement to ensure our clients’ visions are achieved.


Proven Industry Experience – Our team is comprised of senior-level financial services professionals and process experts. Our objective is to address each client’s challenges, provide comprehensive advisory services and strive to deliver results. All of our professionals have significant experience in strategy, transactions, implementation, business, technology and operations.


Collaborative Work Approach – CMA works collaboratively with our clients, our clients’ vendors, and our clients’ partners. We work in close coordination at all levels of the organization and strive to ensure that our expertise and knowledge are transferred for ongoing use.




RSS Financial Times


  • Apple sinks on fears of slowing iPhone sales April 20, 2018
    Shares of Apple fell more than 3% Friday and are down for the whole week too. Worries of soft demand for iPhones --particularly the iPhone X -- hit chip stocks hard too. But Amazon, Netflix and other big techs are still up for the week.
  • Surging oil prices rattle President Trump April 20, 2018
    Trump's Twitter attack on OPEC shows how the oil market has caught him in an awkward spot between pro-business instincts and populist tendencies.
  • Takeda sweetens $60 billion Shire pitch as rival bows out April 20, 2018
    Prospects of a bidding war drove up the stock of biotech firm Shire this week. Now Takeda has the field to itself and has tabled a fourth, slightly sweeter proposal.
  • Connect With Us

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin